Incidence and In-hospital Outcomes of Single-vessel Coronary Chronic Total Occlusion Treated with Percutaneous Coronary Intervention

Overview

Journal Int J Cardiol

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2018 Aug 5

PMID 30075968

Citations 6

Authors

Rajkumar Doshi

Nirav Patel

Rajat Kalra

Harpreet Arora

Navkaranbir S Bajaj

Garima Arora

Pankaj Arora

Affiliations

Soon will be listed here.

Abstract

Background: Coronary chronic total occlusion (CTO) using percutaneous coronary intervention (PCI) presents a distinct challenge in the field of cardiology owing to multiple reasons including the increased risk of peri-procedural complications. We sought to explore rates of hospitalization, outcomes, use of mechanical circulatory support devices, and economic burden associated with single-vessel coronary CTO undergoing PCI for stable coronary artery disease (CAD).

Methods: The National Inpatient Sample spanning from 2008 through 2014 was queried to identify hospitalizations associated with single-vessel coronary CTO-PCI for stable CAD by excluding hospitalizations with ST-elevation and non-ST elevation myocardial infarction. Survey-Specific logistic regression was used to analyze adjusted incidence of in-hospital mortality and acute renal failure.

Results: A total of 109,094 hospitalizations were identified as having single-vessel coronary CTO-PCI for stable CAD from 2008 to 2014. An increasing number of coronary CTO-PCI hospitalizations (2465 to 2688 per 100,000 PCI procedures, P < 0.001) with an overall in-hospital mortality of 0.5% was observed. The rate of in-hospital mortality remained unchanged (P = 0.13), but an increasing rate of acute renal failure was observed in the multivariate-adjusted analysis (P < 0.001). Furthermore, a rise in the utilization of intra-aortic balloon pumps and percutaneous left ventricular assist devices during single-vessel coronary CTO-PCI was noted. Taken together, these may account for increasing costs of hospitalization for single-vessel coronary CTO-PCI ($13,909 in 2008 to $17,729 in 2014, P < 0.001).

Conclusion: In a large retrospective study, slightly increased rates of single-vessel coronary CTO-PCI for stable CAD were observed. This is accompanied by a rise in morbidity and growing healthcare costs.

Citing Articles

Trends and Inhospital Outcomes of Intravascular Imaging on Single-Vessel Coronary Chronic Total Occlusion Treated With Percutaneous Coronary Intervention.

Park D, Hu J, Kanitsoraphan C, Al-Ogaili A, Murthi M, Vardar U Am J Cardiol. 2023; 206:79-85.

PMID: 37683583 PMC: 10901566. DOI: 10.1016/j.amjcard.2023.08.051.

Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes.

Park D, Jamil Y, Hu J, Lowenstern A, Frampton J, Abdullah A Cardiovasc Revasc Med. 2023; 57:60-67.

PMID: 37414611 PMC: 10730763. DOI: 10.1016/j.carrev.2023.06.010.

Chitosan-Based Scaffolds for the Treatment of Myocardial Infarction: A Systematic Review.

Beleno Acosta B, Advincula R, Grande-Tovar C Molecules. 2023; 28(4).

PMID: 36838907 PMC: 9962426. DOI: 10.3390/molecules28041920.

Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia.

Park D, Hu J, Alexander K, Nanna M J Am Geriatr Soc. 2022; 71(4):1034-1046.

PMID: 36409823 PMC: 10089937. DOI: 10.1111/jgs.18120.

In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease.

Park D, Hanna J, Kadian S, Kadian M, Jones W, Al Damluji A J Geriatr Cardiol. 2022; 19(9):631-642.

PMID: 36284680 PMC: 9548058. DOI: 10.11909/j.issn.1671-5411.2022.09.006.

References

Chung C, Nakamura S, Tanaka K, Tanigawa J, Kitano K, Akiyama T . Effect of recanalization of chronic total occlusions on global and regional left ventricular function in patients with or without previous myocardial infarction. Catheter Cardiovasc Interv. 2003; 60(3):368-74. DOI: 10.1002/ccd.10641. View

Mehran R, Aymong E, Nikolsky E, Lasic Z, Iakovou I, Fahy M . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7):1393-9. DOI: 10.1016/j.jacc.2004.06.068. View

Christofferson R, Lehmann K, Martin G, Every N, Caldwell J, Kapadia S . Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005; 95(9):1088-91. DOI: 10.1016/j.amjcard.2004.12.065. View

Stone G, Reifart N, Moussa I, Hoye A, Cox D, Colombo A . Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation. 2005; 112(16):2530-7. DOI: 10.1161/CIRCULATIONAHA.105.583716. View

Cheng A, Selvanayagam J, Jerosch-Herold M, van Gaal W, Karamitsos T, Neubauer S . Percutaneous treatment of chronic total coronary occlusions improves regional hyperemic myocardial blood flow and contractility: insights from quantitative cardiovascular magnetic resonance imaging. JACC Cardiovasc Interv. 2009; 1(1):44-53. DOI: 10.1016/j.jcin.2007.11.003. View

Yeh R, Sidney S, Chandra M, Sorel M, Selby J, Go A . Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362(23):2155-65. DOI: 10.1056/NEJMoa0908610. View

Al-Lamee R, Ielasi A, Latib A, Godino C, Ferraro M, Mussardo M . Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. JACC Cardiovasc Interv. 2011; 4(1):87-95. DOI: 10.1016/j.jcin.2010.08.026. View

Epstein A, Polsky D, Yang F, Yang L, Groeneveld P . Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011; 305(17):1769-76. PMC: 3164857. DOI: 10.1001/jama.2011.551. View

Levine G, Bates E, Blankenship J, Bailey S, Bittl J, Cercek B . 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and.... J Am Coll Cardiol. 2011; 58(24):e44-122. DOI: 10.1016/j.jacc.2011.08.007. View

10.

Patel V, Brayton K, Tamayo A, Mogabgab O, Michael T, Lo N . Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013; 6(2):128-36. DOI: 10.1016/j.jcin.2012.10.011. View

11.

Harold J, Bass T, Bashore T, Brindiss R, Brush Jr J, Burke J . ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: a Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical.... Catheter Cardiovasc Interv. 2013; 82(2):E69-111. DOI: 10.1002/ccd.24985. View

12.

Michael T, Karmpaliotis D, Brilakis E, Alomar M, Abdullah S, Kirkland B . Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter United States registry. Catheter Cardiovasc Interv. 2014; 85(3):393-9. PMC: 4090298. DOI: 10.1002/ccd.25359. View

13.

Bagnall A, Spyridopoulos I . The evidence base for revascularisation of chronic total occlusions. Curr Cardiol Rev. 2014; 10(2):88-98. PMC: 4021288. DOI: 10.2174/1573403x10666140331125659. View

14.

El Sabbagh A, Patel V, Jeroudi O, Michael T, Alomar M, Mogabgab O . Angiographic success and procedural complications in patients undergoing retrograde percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 3,482 patients from 26 studies. Int J Cardiol. 2014; 174(2):243-8. DOI: 10.1016/j.ijcard.2014.04.004. View

15.

Brilakis E, Banerjee S, Karmpaliotis D, Lombardi W, Tsai T, Shunk K . Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015; 8(2):245-253. DOI: 10.1016/j.jcin.2014.08.014. View

16.

Jang W, Yang J, Choi S, Song Y, Hahn J, Choi J . Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv. 2015; 8(2):271-279. DOI: 10.1016/j.jcin.2014.10.010. View

17.

Christakopoulos G, Christopoulos G, Carlino M, Jeroudi O, Roesle M, Rangan B . Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015; 115(10):1367-75. DOI: 10.1016/j.amjcard.2015.02.038. View

18.

Khera R, Cram P, Lu X, Vyas A, Gerke A, Rosenthal G . Trends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012. JAMA Intern Med. 2015; 175(6):941-50. PMC: 4780323. DOI: 10.1001/jamainternmed.2014.7856. View

19.

Tomasello S, Boukhris M, Giubilato S, Marza F, Garbo R, Contegiacomo G . Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015; 36(45):3189-98. DOI: 10.1093/eurheartj/ehv450. View

20.

Zhang Q, Chen L, Li M, Cui Y, Zhao C, Cui L . Influence of chronic kidney disease on the outcome of patients with chronic total occlusion. Am J Transl Res. 2016; 8(1):196-208. PMC: 4759429. View